Summary Company Announcement Date: July 22, 2022 FDA Publish Date: July 23, 2022 Product Type: Food & Beverages Meal Replacements Allergens Reason for Announcement: Recall Reason Description Undeclared milk Company Name: Nature’s Sunshine Products Inc. Brand Name: Brand Name(s) Product Description: Product Description Whey Protein & Power Herbs Company Announcement July 22, 2022 – Nature’s…
Middleburg Nurse Sentenced to Federal Prison for Tampering with ICU Patients’ Medication
Department of JusticeMiddle District of Florida FOR IMMEDIATE RELEASEWednesday, July 20, 2022 Jacksonville, Florida – Chief U.S. District Judge Timothy J. Corrigan has sentenced Monique Elizabeth Carter (36, Middleburg) to one year and one day in federal prison for tampering with a consumer product, specifically, injectable fentanyl. The court further ordered that after serving her prison…
Pharmacist Pleads Guilty to Misappropriating and Adulterating Prescription Pain Medication
Department of JusticeDistrict of Minnesota FOR IMMEDIATE RELEASEWednesday, July 20, 2022 MINNEAPOLIS – A Minneapolis woman has pleaded guilty to misappropriating and adulterating prescription morphine while working as a pharmacist, announced U.S. Attorney Andrew M. Luger. According to court documents, on October 30, 2019, Jennifer Lee Draheim, 42, a pharmacist at Coburn’s Pharmacy in Ramsey, removed…
Two Florida Medical Study Coordinators Plead Guilty in Connection with Scheme to Falsify Clinical Trial Data
U.S. Department of Justice FOR IMMEDIATE RELEASEWednesday, July 20, 2022 Two Florida women pleaded guilty today in connection with their participation in a conspiracy to falsify clinical trial data. According to court documents, Analay Rico, 37, of Fort Lauderdale, and Daylen Diaz, 44, of Miami, worked as study coordinators at a clinical research site called Tellus…
Enjoy Life Natural Brands, LLC Expands Voluntary Recall of Select Bakery Products Due to Potential Presence of Foreign Material
Summary Company Announcement Date: July 20, 2022 FDA Publish Date: July 22, 2022 Product Type: Food & Beverages Snack Food Item Contaminants Reason for Announcement: Recall Reason Description Potential presence of plastic pieces Company Name: Enjoy Life Natural Brands, LLC Brand Name: Brand Name(s) Enjoy Life & Trader Joe’s Product Description: Product Description Soft Baked…
Natural Grocers® Issues Voluntary Recall on Organic Amaranth Grain Due to Potential Presence of Salmonella
Summary Company Announcement Date: July 22, 2022 FDA Publish Date: July 22, 2022 Product Type: Food & Beverages Foodborne Illness Reason for Announcement: Recall Reason Description Potential Salmonella contamination Company Name: Vitamin Cottage Natural Food Markets, Inc. Brand Name: Brand Name(s) Natural Grocers Product Description: Product Description Organic Amaranth Grain Company Announcement LAKEWOOD, Colo. (July…
Voluntary Recall of Certain Over-the-Counter Products
Summary Company Announcement Date: July 21, 2022 FDA Publish Date: July 21, 2022 Product Type: Drugs Reason for Announcement: Recall Reason Description Products stored outside of temperature requirements Company Name: Family Dollar Brand Name: Brand Name(s) Multiple brands Product Description: Product Description Multiple OTC Medical Products Company Announcement Family Dollar is initiating a voluntary retail…
Eat Just, Inc. Recalls Just Egg Chopped Spring Greens Because of Possible Health Risk
Summary Company Announcement Date: July 20, 2022 FDA Publish Date: July 21, 2022 Product Type: Food & Beverages Reason for Announcement: Recall Reason Description Potential Listeria monocytogenes Company Name: Eat Just, Inc. Brand Name: Brand Name(s) Spring Green Flavor Product Description: Product Description Chopped Egg and Vegetables Company Announcement Eat Just, Inc. (“Eat Just”), located…
FDA D.I.S.C.O. Burst Edition: FDA approval of Breyanzi (lisocabtagene maraleucel) for second-line treatment of large B-cell lymphoma
Podcast Welcome back to the D.I.S.C.O., FDA’s Drug Information Soundcast in Clinical Oncology, Burst Edition, brought to you by FDA’s Division of Drug Information in partnership with FDA’s Oncology Center of Excellence. Today we’ll provide another quick update on a recent FDA cancer drug approval. On June 24, 2022, the FDA approved lisocabtagene maraleucel (brand…
UPDATE: Use of Renuvion/J-Plasma Device for Certain Aesthetic Procedures: FDA Safety Communication
Date Issued: July 21, 2022 The U.S. Food and Drug Administration (FDA) is providing another update on the Renuvion/J-Plasma device system by Apyx Medical about use of the device for certain aesthetic skin procedures. In March 2022, the FDA warned against the use of Renuvion/J-Plasma for procedures intended to improve the appearance of the skin…